UK calls for access to new AMD therapies

Article

Quantitative analysis of the impact of neovascular age-related macular degeneration (AMD) on the UK population has led a team of researchers to call for urgent, early access to the new class of drug therapies for the disease.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
Related Content
A hand pushes a triangle-shaped tangram block into a colorful collection of other triangle blocks, all in various sizes. Image credit: ©Freer – stock.adobe.com

Study describes ‘triangle sign’ as key to differentiating total choroidal detachments and suprachoroidal hemorrhages

Lynda Charters
January 24th 2025
Article

Ultrasounds reveal the distinct feature within the vitreous anterior, a promising diagnostic indicator for ocular pathologies

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

An elderly man undergoes an eye exam in a clinic. Image credit: ©Vladislav – stock.adobe.com

NeurEYE research team leads AI-supported dementia detection programme with Scottish optometrists

Hattie Hayes
January 22nd 2025
Article

Predictive software will use retinal imaging to identify patient risk for Alzheimer and other neurodegenerative diseases

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A physician helps a patient undergo microperimetry imaging with the iCare MAIA. Image courtesy of iCare.

iCare announces updated MAIA TrueColor Microperimetry System

Grace Koennecke
January 20th 2025
Article

The updated device is designed to meet market diagnostic needs, including within geographic atrophy research

The office of the Agence Nationale de Sécurité du Médicament in Saint-Denis, France. ©HJBC – stock.adobe.com

PulseSight Therapeutics submits Clinical Trial Authorisation for phase I trial of PST-611

Hattie Hayes
January 16th 2025
Article

The transferrin vectorised therapy is being investigated for use in patients with dry age-related macular degeneration and geographic atrophy

© 2025 MJH Life Sciences

All rights reserved.